Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Trivedi Global, Inc. and James Jeffery Peoples Announce Preclinical Research of Biofield Energy Treated Supplement to Enhance Immunity, Reduce Inflammatory Disorders

Trivedi Global Inc
Posted on: 26 Aug 18
Trivedi Global, Inc. and James Jeffery Peoples Announce Preclinical Research of Biofield Energy Treated Supplement to Enhance Immunity, Reduce Inflammatory Disorders Over 50% improvement in overall immunity.

PR Newswire

CAMBRIDGE, Mass., Aug. 26, 2018

CAMBRIDGE, Mass., Aug. 26, 2018 /PRNewswire-PRWeb/ -- James Jeffery Peoples, a scientifically validated energy healer, today announces the impact of a biofield energy treated proprietary nutraceutical product to improve immune function response and to fight a wide range of autoimmune and inflammatory disorders.

The preclinical research assessed biomarkers for immune function, as well as, inflammation and reported significant improvement in overall immunity. The following data was reported:

  • Over 50% increase in delayed hypersensitivity reaction
  • Over 10% increase in phosphorus levels

The research findings suggest that this biofield energy treatment enhanced the nutraceutical's anti-inflammatory and immunomodulatory properties. This data is promising, whereas, inflammation is a known contributor to many of today's most common diseases.

Furthermore, the research suggests that this holistic medicine can also be used for anti-aging, stress prevention and management, and in the improvement of overall health and the quality of life.

Overall, the results indicate great promise as a complementary and alternative medicine supplement, with a safe therapeutic index, to combat a wide range of autoimmune disorders. Such conditions may include Lupus, Systemic Lupus Erythematosus, Fibromyalgia, Addison's Disease, Hashimoto Thyroiditis, Celiac Disease (gluten-sensitive enteropathy), Multiple Sclerosis, Dermatomyositis, Graves' Disease, Scleroderma, Psoriasis, Rheumatoid Arthritis, Type 1 Diabetes, Sjogren Syndrome, Crohn's Disease, Vasculitis, Vitiligo, Chronic Fatigue Syndrome and Alopecia Areata; as well as, inflammatory disorders such as Irritable Bowel Syndrome (IBS), Asthma, Ulcerative Colitis, Alzheimer's Disease, Parkinson's Disease, Atherosclerosis, Dermatitis, Hepatitis and Diverticulitis.

Peoples provided this Biofield Energy Treatment as part of a group of 20 Biofield Energy Healers. Thirteen were remotely located in the United States of America, five were located in Canada, and two were located in Australia.

The tested formulation was located in the research laboratory of Dabur Research Foundation, near New Delhi, India.

This Biofield Energy Treatment was administered for 5 minutes through the healers' unique Energy Transmission process remotely to the test formulation under laboratory conditions. None of the Biofield Energy Healers in this study visited the laboratory in person, nor had any contact with the nutraceutical samples.

About Biofield Energy Treatments
The National Center of Complementary and Integrative Health (NCCIH) has recognized and accepted Biofield Energy Healing Treatments as a complementary and alternative medicine (CAM) health care approach in addition to other therapies, medicines, and practices. CAM therapies have been practiced worldwide with reported clinical benefits in different health disease profiles. Human Biofield Energy has subtle energy that has the capacity to work in an effective manner. This energy can be harnessed and transmitted by the gifted into living and non-living things via the process of a Biofield Energy Healing Treatment or Therapy.

Scientific Publication

Title: Immunomodulatory Activity of Biofield Energy Healing Based Herbomineral Formulation in Sprague Dawley Rats: Evidence for Humoral and Cell-Mediated Responses

Journal: American Journal of Health Research

Published: December 11, 2017

URL: https://www.trivedieffect.com/the-science/biotech/publication/healers-science/nutraceuticals/immunomodulatory-activity-of-biofield-energy-healing-based-herbomineral-formulation-in-sprague-dawley-rats-evidence-for-humoral-and-cell-mediated-responses/

About James Jeffrey Peoples
James Jeffery Peoples, known as Jeff Peoples, is a successful entrepreneur, leader, and business architect. Peoples has helped thousands of businesses save billions of dollars in mailing, shipping, and labor costs since 1988. He is passionate about helping companies to become more efficient and profitable and helping their people reach their next best level of growth and prosperity through automating information.

Peoples founded Window Book, Inc. in 1988, and built it into a leader in the postal and logistics software industry with over 60 full-time staff in three countries serving thousands of clients. Currently over half of all American business mail is produced by Window Book's clients using its information automation software. Peoples has created and led multiple companies to success by bringing to market advanced technologies and better ways of living.

In 2011, Peoples was introduced to Guruji Mahendra Trivedi. Through Guruji Trivedi's blessings and guidance, Peoples has developed his owner innate talents for harnessing and transmitting life force energy for the benefit and improvement of the receiver. Peoples leading-edge scientific research is focused on improving the next generation of health products that will serve billions of people with better health and enable them to love and enjoy God's creation at a higher level.
http://www.jeffpeoples.tv

About Guruji Mahendra Trivedi & The Trivedi Effect®
Guruji Mahendra Kumar Trivedi, the founder of the Trivedi Effect®, is on a mission to usher in a new era that integrates science, spirituality, and consciousness to vastly improve the human condition and benefit humanity on a global scale. To date, more than 250,000 people worldwide have benefited from the Trivedi Effect®. His organization, Trivedi Global, Inc., is collaborating with globally renowned product research and development organizations to bring to market proprietary products and therapies in the areas of nutraceuticals, pharmaceuticals, and more. Alice Branton, CEO, Trivedi Global, Inc., recently spoke on the impact of the Trivedi Effect® at the Entrepreneurship Club of the Harvard Business School, Nasdaq, Microsoft, and Coca-Cola. She also appeared on more than 35 network television news shows in the last year including ABC, NBC, FOX, CW and more. Dahryn Trivedi, a prodigious spiritual leader, young entrepreneur, inspiring speaker and paradigm-shifting scientist also joins in the mission.

The Trivedi Effect® is an evidence-based phenomenon in which an individual can harness inherently intelligent energy from nature and transmit it to living organisms and non-living materials, anywhere in the world through thought intention, to significantly enhance potency and beneficially alter their characteristics and behaviors through transformation at the atomic, molecular, and cellular levels.

The Trivedi Effect® has been tested, measured, and validated in over 4,000 scientific experiments globally, by world-renowned scientists and research institutes using the rigor of internationally accepted models of scientific research with the most sophisticated technologies available on this planet. Challenging the known frontiers of science, this research has resulted in over 350 publications in major international peer-reviewed scientific journals with over 4,000 citations.
These publications are available in over 3,500 universities internationally including the prestigious Ivy League Universities, as well as, the National Institutes of Health (NIH).
http://www.TrivediEffect.com

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause actual results in future periods to differ materially from stated results. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. Statements in this news release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, and orientations regarding the future. Often, but not always, forward-looking statements can be identified by words such as "may", "will", "should", "would", "expect", "intend", "plan", "anticipate", "believe", "estimate", "predict", "potential", "seem", "seek", "future", "continue", "appear", or variations of such words including negative variations thereof, and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved.

Media Contacts
James Jeffery Peoples
(617) 510-5194
Jeff@JeffPeoples.TV

Alice Branton,
Chief Executive Officer
Trivedi Global, Inc.
(702) 907-8864
pr@trivedieffect.com

SOURCE Trivedi Global Inc

PR Newswire
www.prnewswire.com

Last updated on: 26/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.